Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms
API maker begins circulation of second and final call money notice for partly paid-up rights shares, completing the last leg of its 2024 fundraising cycle
Subscribe To Our Newsletter & Stay Updated
